ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
99,700
-11,200 (-10.10%)
Aug 21, 2026, 3:30 PM KST

ST Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
111,27330,54663,40550,09750,20139,203
Short-Term Investments
3,803-9,51840,000-44,000
Trading Asset Securities
84,01460,44448,001--10,013
Cash & Short-Term Investments
199,09090,990120,92490,09750,20193,216
Cash Growth
67.06%-24.75%34.22%79.47%-46.15%-33.72%
Accounts Receivable
37,51996,66167,846120,56694,21062,949
Other Receivables
-1,7681,9721,5003,1311,499
Receivables
37,51998,91369,817122,06697,34164,448
Inventory
194,524169,471126,963120,736107,62380,809
Prepaid Expenses
7,3937,7389,12011,9015,8185,039
Other Current Assets
6,6795,5553,2543,5772,251628.76
Total Current Assets
445,206372,668330,078348,378263,234244,142
Property, Plant & Equipment
358,991359,334338,695280,105257,885210,190
Long-Term Investments
4,8838,1128,91310,72811,49213,264
Goodwill
-11,80810,5999,9508,9478,455
Other Intangible Assets
17,2835,1985,9333,5133,5324,164
Long-Term Deferred Tax Assets
15,68216,5027,3527,49817,12715,732
Other Long-Term Assets
7,8978,52220,30515,2648,4362,619
Total Assets
849,943782,567721,876675,436570,652498,565

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
18,65711,79610,64617,66118,09512,865
Accrued Expenses
-11,6564,5668,2649,3656,558
Short-Term Debt
72,01976,53363,88320,878105,854-
Current Portion of Long-Term Debt
--8,3338,3338,29315,000
Current Portion of Leases
1,5971,2531,1581,0391,185587.24
Current Income Taxes Payable
10,1898,5397,1154,4302,3771,322
Current Unearned Revenue
-5,7986,8182,391--
Other Current Liabilities
111,96249,17630,76120,74834,05416,243
Total Current Liabilities
214,424164,752133,28183,745179,22452,575
Long-Term Debt
--43,255159,68916,70791,451
Long-Term Leases
715.33929.221,5122,1432,481479.1
Long-Term Unearned Revenue
-2,5522,7382,791-956.3
Pension & Post-Retirement Benefits
636.45604.52766.09584.87--
Other Long-Term Liabilities
22,91720,72637,33339,57831,13827,071
Total Liabilities
238,693189,563218,885288,530229,549172,533

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10,41910,35110,0769,4049,4049,404
Additional Paid-In Capital
374,353358,218315,593225,940195,747195,714
Retained Earnings
208,769204,243159,437135,729126,893115,590
Comprehensive Income & Other
18,05920,63118,02513,4765,5872,266
Total Common Equity
611,599593,443503,132384,550337,632322,974
Minority Interest
-349.45-438.89-141.192,3563,4713,058
Shareholders' Equity
611,250593,004502,991386,906341,103326,033
Total Liabilities & Equity
849,943782,567721,876675,436570,652498,565

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
74,33178,714118,142192,082134,521107,517
Net Cash (Debt)
124,75912,2762,782-101,984-84,320-14,301
Net Cash Growth
13599.88%341.27%----
Net Cash Per Share
5766.33572.43142.64-5422.17-4483.00-766.21
Filing Date Shares Outstanding
20.8420.720.1518.8118.8118.81
Total Common Shares Outstanding
20.8420.720.1518.8118.8118.81
Working Capital
230,782207,916196,797264,63484,010191,567
Book Value Per Share
29349.6628666.3924965.7720445.2617950.7617171.46
Tangible Book Value
594,316576,437486,600371,088325,153310,355
Tangible Book Value Per Share
28520.2727844.9124145.4419729.5017287.3016500.56
Land
-60,44960,20060,02459,99952,910
Buildings
-204,219149,266146,984118,168102,362
Machinery
-284,708203,768195,642157,855120,141
Construction In Progress
-5,28293,14920,79444,42150,144